['Wait and see' in paediatric epilepsy. Our experience]

B Salinas-Salvador1, A Moreno-Sánchez1, G Carmen-Marcén1

  • 1HUMS. Hospital Universitario Miguel Servet, 50009 Zaragoza, España.

Revista De Neurologia
|January 27, 2023
PubMed

Insights

Pharmacological treatment for epilepsy in children should consider quality of life and neurodevelopment over seizure frequency alone. Decisions on antiepileptic drugs require parental agreement.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Context:

  • Epilepsy management in children often involves pharmacological treatment.
  • Current treatments aim to control seizures but do not offer a cure.
  • The decision to initiate treatment is complex and impacts a child's life.

Purpose:

  • To analyze the outcomes of children with non-symptomatic seizures who did not receive pharmacological treatment.
  • To evaluate the experience with untreated epilepsy in a pediatric neurology setting.

Summary:

  • A study analyzed 65 children with non-symptomatic seizures, some experiencing single or multiple events.
  • Electroencephalogram and neuroimaging findings varied, with a significant portion showing abnormalities.
  • Follow-up periods averaged 2.7 to 3.8 years, observing seizure patterns and characteristics.

Impact:

  • Treatment decisions for childhood epilepsy should prioritize quality of life and neurodevelopment.
  • Parental involvement and agreement are crucial in managing antiepileptic drug therapy.
  • This approach may lead to more individualized and less aggressive treatment strategies.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
240
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
516
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
501
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
461